Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Paper
  • Published:

Bystander effect of purine nucleoside analogues in HSV-1tk suicide gene therapy is superior to that of pyrimidine nucleoside analogues

Gene Therapy volume 6, pages 162–170 (1999)Cite this article

Abstract

Introduction of the herpes simplex virus type 1 thymidine kinase gene into tumor cells, followed by the administration of the antiherpes nucleoside analogue ganciclovir has been demonstrated to be effective in eliminating solid tumors in animals. The success of this combination treatment largely depends on the bystander effect, ie the killing of nontransfected tumor cells by activated drug carried over from the nearby herpes thymidine kinase (tk) gene-transfected cells. We evaluated the in vitro bystander effect of several antiherpes purine and pyrimidine nucleoside analogues, using a colorimetric assay. All pyrimidine nucleoside analogues, including (E)-5-(2-bromovinyl)-2′-deoxyuridine (BVDU), showed low, if any, bystander killing effect. In contrast, purine nucleoside analogues, such as ganciclovir, were endowed with a pronounced bystander killer effect. Lobucavir (Cyclobut-G), a ganciclovir analogue, displayed a two- to three-fold more pronounced bystander killer effect than ganciclovir, eliminating, at a concentration of 10 μM, 75% and 90% of a cell population that contained 5% and 10% tk gene-transfected cells, respectively. These findings were corroborated by autoradiographic analysis that showed that 2′-3H-BVDU metabolites formed in the herpes tk gene-transfected tumor cells were much less efficiently incorporated in the DNA of bystander cells than 8-3H-GCV. This indicates that, under the same experimental conditions, BVDU metabolites are less prone to pass the gap junctions than GCV metabolites.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  1. Culver KW et al. In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors Science 1992 256: 1550–1552

    Article  CAS  PubMed  Google Scholar 

  2. Ram Z et al. In situ retrovirus-mediated gene transfer for the treatment of brain tumors in rats Cancer Res 1993 53: 83–88

    CAS  PubMed  Google Scholar 

  3. Human gene marker/therapy clinical protocols Hum Gene Ther 1996 7: 1621–1647

  4. Balzarini J, De Clercq E, Ayusawa D, Seno T . Murine mammary FM3A carcinoma cells transformed with the herpes simplex virus type 1 thymidine kinase gene are highly sensitive to the growth-inhibitory properties of (E)-5-(2-bromovinyl)-2′-deoxyuridine and related compounds FEBS Lett 1985 185: 95–100

    Article  CAS  PubMed  Google Scholar 

  5. Balzarini J, Bohman C, De Clercq E . Differential mechanism of cytostatic effect of (E)-5-(2-bromovinyl)-2′-deoxyuridine, 9-(1,3-dihydroxy-2-propoxymethyl)guanine, and other antiherpetic drugs on tumor cells transfected by the thymidine kinase gene of herpes simplex virus type 1 or type 2 J Biol Chem 1993 268: 6332–6337

    CAS  PubMed  Google Scholar 

  6. Balzarini J, Bohman C, Walker RT, De Clercq E . Comparative cytostatic activity of different antiherpetic drugs against herpes simplex virus thymidine kinase gene-transfected tumor cells Mol Pharmacol 1994 45: 1253–1258

    CAS  PubMed  Google Scholar 

  7. Balzarini J et al. Novel (E)-5-(2-iodovinyl)-2′-deoxyuridine derivatives as potential cytostatic agents against herpes simplex virus thymidine kinase gene transfected tumors Gene Therapy 1995 2: 317–322

    CAS  PubMed  Google Scholar 

  8. Balzarini J et al. Superior cytostatic activity of the ganciclovir elaidic acid ester due to the prolonged intracellular retention of ganciclovir anabolites in herpes simplex virus type 1 thymidine kinase gene-transfected tumor cells Gene Therapy 1998 5: 419–426

    Article  CAS  PubMed  Google Scholar 

  9. Degrève B et al. Varicella-zoster virus thymidine kinase gene and antiherpetic pyrimidine nucleoside analogues in a combined gene/chemotherapy treatment for cancer Gene Therapy 1997 4: 1107–1114

    Article  PubMed  Google Scholar 

  10. Short MP et al. Gene delivery to glioma cells in rat brain by grafting of a retrovirus packaging cell line J Neurosci Res 1990 27: 427–433

    Article  CAS  PubMed  Google Scholar 

  11. Smythe WR et al. Successful adenovirus-mediated gene transfer in an in vivo model of human malignant mesothelioma AnnThorac Surg 1994 57: 1395–1401

    Article  CAS  Google Scholar 

  12. Ram Z et al. Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells Nature Med 1997 12: 1354–1361

    Article  Google Scholar 

  13. Freeman SM et al. The ‘bystander effect’: tumor regression when a fraction of the tumor mass is genetically modified Cancer Res 1993 53: 5274–5283

    CAS  PubMed  Google Scholar 

  14. Bi WL, Parysek LM, Warnick R, Stambrook PJ . In vitro evidence that metabolic cooperation is responsible for the bystander effect observed with HSVtk retroviral gene therapy Hum Gene Ther 1993 4: 725–731

    Article  CAS  PubMed  Google Scholar 

  15. Ishii-Morita H et al. Mechanism of ‘bystander effect’ killing in the herpes simplex thymidine kinase gene therapy model of cancer treatment Gene Therapy 1997 4: 244–251

    Article  CAS  PubMed  Google Scholar 

  16. Mesnil M et al. Bystander killing of cancer cells by herpes simplex virus thymidine kinase gene is mediated by connexins Proc Natl Acad Sci USA 1996 93: 1831–1835

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Elshami AA et al. Gap junctions play a role in the ‘bystander effect’ of the herpes simplex virus thymidine kinase/ganciclovir system in vitro Gene Therapy 1996 3: 85–92

    CAS  PubMed  Google Scholar 

  18. Fick J et al. The extent of heterocellular communication mediated by gap junctions is predictive of bystander tumor cytotoxicity in vitro Proc Natl Acad Sci USA 1995 92: 11071–11075

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Dilber MS et al. Gap junctions promote the bystander effect of herpes simplex virus thymidine kinase in vivo Cancer Res 1997 57: 1523–1528

    CAS  PubMed  Google Scholar 

  20. Park JY et al. Retinoids augment the bystander effect in vitro and in vivo in herpes simplex virus thymidine kinase/ganciclovir-mediated gene therapy Gene Therapy 1997 4: 909–917

    Article  CAS  PubMed  Google Scholar 

  21. Yamasaki H . Gap junctional intercellular communication and carcinogenesis Carcinogenesis 1990 11: 1051–1058

    Article  CAS  PubMed  Google Scholar 

  22. Freeman SM et al. The treatment of ovarian cancer with a gene-modified cancer vaccine: a phase I study Hum Gene Ther 1995 6: 927–939

    Article  CAS  PubMed  Google Scholar 

  23. Marini III FC, Nelson JA, Lapeyre J-N . Assessment of bystander effect potency produced by intratumoral implantation of HSVtk-expressing cells using surrogate marker secretion to monitor tumor growth kinetics Gene Therapy 1995 2: 655–659

    Google Scholar 

  24. Caruso M et al. Regression of established macroscopic liver metastases after in situ transduction of a suicide gene Proc Natl Acad Sci USA 1993 90: 7024–7028

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Vile RG et al. Systemic gene therapy of murine melanoma using tissue specific expression of the HSVtk gene involves an immune component Cancer Res 1994 54: 6228–6234

    CAS  PubMed  Google Scholar 

  26. Ram Z et al. The effect of thymidine kinase transduction and ganciclovir therapy on tumor vasculature and growth of 9L gliomas in rats J Neurosurg 1994 81: 256–260

    Article  CAS  PubMed  Google Scholar 

  27. Balzarini J et al. 5-Substituted 2′-deoxyuridines: correlation between inhibition of tumor cell growth and inhibition of thymidine kinase and thymidylate synthetase Biochem Pharmacol 1982 31: 3673–3682

    Article  CAS  PubMed  Google Scholar 

  28. Subak-Sharpe JH, Burk RR, Pitts JD . Metabolic cooperation by cell to cell transfer between genetically different mammalian cells Heredity 1966 21: 342–343

    Google Scholar 

  29. Subak-Sharpe JH, Burk RR, Pitts JD . Metabolic cooperation between biochemically marked mammalian cells in tissue culture J Cell Sci 1969 4: 353–367

    CAS  PubMed  Google Scholar 

  30. Fujimoto WY, Subak-Sharpe JH, Seegmiller JE . Hypoxanthine-guanine phosphoribosyltransferase deficiency: chemical agents selective for mutant or normal cultured fibroblasts in mixed and heterozygote cultures Proc Natl Acad Sci USA 1971 7: 1516–1519

    Article  Google Scholar 

  31. Myhr BC, DiPaolo JA . Requirement for cell dispersion prior to selection of induced azaguanine-resistant colonies of Chinese hamster cells Genetics 1975 80: 157–169

    CAS  PubMed  PubMed Central  Google Scholar 

  32. Dickerman LH, Tischfield JA . Comparative effects of adenine analogs upon metabolic cooperation between hamster cells with different levels of adenine phosphoryibosyltransferase activity Mutat Res 1978 49: 83–94

    Article  CAS  PubMed  Google Scholar 

  33. Bevans CG, Kordel M, Rhee SK, Harris AL . Isoform composition of connexin channels determines selectivity among second messengers and uncharged molecules J Biol Chem 1998 273: 2808–2816

    Article  CAS  PubMed  Google Scholar 

  34. Cao R et al. A quantitative analysis of connexin-specific permeability differences of gap junctions expressed in HeLa transfectants and Xenopus oocytes J Cell Sci 1998 111: 31–43

    CAS  PubMed  Google Scholar 

  35. Veenstra RD et al. Selectivity of connexin-specific gap junctions does not correlate with channel conductance Circulation Res 1995 77: 1156–1165

    Article  CAS  PubMed  Google Scholar 

  36. Veenstra RD . Size and selectivity of gap junction channels formed from different connexins J Bioenerg Biomembr 1996 28: 327–337

    Article  CAS  PubMed  Google Scholar 

  37. Degrève B et al. Differential intracellular compartmentation of herpetic thymidine kinases (tks) in tk gene-transfected tumor cells. Molecular characterization of the nuclear localization signal of herpes simplex virus type 1 tk J Virol 1998; 72 (in press)

Download references

Author information

Authors and Affiliations

  1. Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, Leuven, Belgium

    B Degrève, E De Clercq & J Balzarini

Authors
  1. B Degrève
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E De Clercq
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J Balzarini
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Degrève, B., De Clercq, E. & Balzarini, J. Bystander effect of purine nucleoside analogues in HSV-1tk suicide gene therapy is superior to that of pyrimidine nucleoside analogues. Gene Ther 6, 162–170 (1999). https://doi.org/10.1038/sj.gt.3300806

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.gt.3300806

Keywords

This article is cited by

Search

Advanced search

Quick links